These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17574288)

  • 1. Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells.
    Blanco E; Bey EA; Dong Y; Weinberg BD; Sutton DM; Boothman DA; Gao J
    J Control Release; 2007 Oct; 122(3):365-74. PubMed ID: 17574288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.
    Ma X; Huang X; Moore Z; Huang G; Kilgore JA; Wang Y; Hammer S; Williams NS; Boothman DA; Gao J
    J Control Release; 2015 Feb; 200():201-11. PubMed ID: 25542645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Lapachone and Paclitaxel Combination Micelles with Improved Drug Encapsulation and Therapeutic Synergy as Novel Nanotherapeutics for NQO1-Targeted Cancer Therapy.
    Zhang L; Chen Z; Yang K; Liu C; Gao J; Qian F
    Mol Pharm; 2015 Nov; 12(11):3999-4010. PubMed ID: 26415823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology-enabled delivery of NQO1 bioactivatable drugs.
    Ma X; Moore ZR; Huang G; Huang X; Boothman DA; Gao J
    J Drug Target; 2015; 23(7-8):672-80. PubMed ID: 26453163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermolecular Interactions between Coencapsulated Drugs Inhibit Drug Crystallization and Enhance Colloidal Stability of Polymeric Micelles.
    Zhang L; Sun H; Chen Z; Liu Z; Huang N; Qian F
    Mol Pharm; 2017 Oct; 14(10):3568-3576. PubMed ID: 28829143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodrug strategy to achieve lyophilizable, high drug loading micelle formulations through diester derivatives of β-Lapachone.
    Ma X; Huang X; Huang G; Li L; Wang Y; Luo X; Boothman DA; Gao J
    Adv Healthc Mater; 2014 Aug; 3(8):1210-6. PubMed ID: 24532286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy.
    Blanco E; Bey EA; Khemtong C; Yang SG; Setti-Guthi J; Chen H; Kessinger CW; Carnevale KA; Bornmann WG; Boothman DA; Gao J
    Cancer Res; 2010 May; 70(10):3896-904. PubMed ID: 20460521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin Delivery by Poly(Lactide)-Based Co-Polymeric Micelles: An In Vitro Anticancer Study.
    Kumari P; Swami MO; Nadipalli SK; Myneni S; Ghosh B; Biswas S
    Pharm Res; 2016 Apr; 33(4):826-41. PubMed ID: 26597940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone.
    Bey EA; Bentle MS; Reinicke KE; Dong Y; Yang CR; Girard L; Minna JD; Bornmann WG; Gao J; Boothman DA
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11832-7. PubMed ID: 17609380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of various formulation approaches for the application of beta-lapachone in prostate cancer therapy.
    Wu X; Kasselouri A; Vergnaud-Gauduchon J; Rosilio V
    Int J Pharm; 2020 Apr; 579():119168. PubMed ID: 32087264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells.
    Choi EK; Terai K; Ji IM; Kook YH; Park KH; Oh ET; Griffin RJ; Lim BU; Kim JS; Lee DS; Boothman DA; Loren M; Song CW; Park HJ
    Neoplasia; 2007 Aug; 9(8):634-42. PubMed ID: 17786182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosome-oriented, dual-stage pH-responsive polymeric micelles for β-Lapachone delivery.
    Zhou Y; Dong Y; Huang G; Wang Y; Huang X; Zhang F; Boothman DA; Gao J; Liang W
    J Mater Chem B; 2016 Dec; 4(46):7429-7440. PubMed ID: 28580145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy.
    Li LS; Bey EA; Dong Y; Meng J; Patra B; Yan J; Xie XJ; Brekken RA; Barnett CC; Bornmann WG; Gao J; Boothman DA
    Clin Cancer Res; 2011 Jan; 17(2):275-85. PubMed ID: 21224367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock increases expression of NAD(P)H:quinone oxidoreductase (NQO1), mediator of beta-lapachone cytotoxicity, by increasing NQO1 gene activity and via Hsp70-mediated stabilisation of NQO1 protein.
    Dong GZ; Youn H; Park MT; Oh ET; Park KH; Song CW; Choi EK; Park HJ
    Int J Hyperthermia; 2009; 25(6):477-87. PubMed ID: 19657853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin enhances the anticancer effect of beta-lapachone by upregulating NQO1.
    Terai K; Dong GZ; Oh ET; Park MT; Gu Y; Song CW; Park HJ
    Anticancer Drugs; 2009 Nov; 20(10):901-9. PubMed ID: 19738461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers.
    Tumbath S; Jiang L; Li X; Zhang T; Zahid KR; Zhao Y; Zhou H; Yin Z; Lu T; Jiang S; Chen Y; Chen X; Fu YX; Huang X
    Oncoimmunology; 2024; 13(1):2363000. PubMed ID: 38846085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism.
    Silvers MA; Deja S; Singh N; Egnatchik RA; Sudderth J; Luo X; Beg MS; Burgess SC; DeBerardinis RJ; Boothman DA; Merritt ME
    J Biol Chem; 2017 Nov; 292(44):18203-18216. PubMed ID: 28916726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCNA inhibition enhances the cytotoxicity of β-lapachone in NQO1-Positive cancer cells by augmentation of oxidative stress-induced DNA damage.
    Su X; Wang J; Jiang L; Chen Y; Lu T; Mendonca MS; Huang X
    Cancer Lett; 2021 Oct; 519():304-314. PubMed ID: 34329742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol-conjugated poly(D, L-lactide)-based micelles as a nanocarrier system for effective delivery of curcumin in cancer therapy.
    Kumari P; Muddineti OS; Rompicharla SV; Ghanta P; B B N AK; Ghosh B; Biswas S
    Drug Deliv; 2017 Nov; 24(1):209-223. PubMed ID: 28156164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.